Bicara Therapeutics Inc.
BCAX
$18.82
$0.663.63%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 290.17M | 436.61M | 462.07M | 489.71M | 520.76M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.21M | 7.79M | 8.69M | 12.82M | 756.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 297.37M | 444.39M | 470.75M | 502.53M | 521.51M |
|
|
|||||
| Total Current Assets | 297.37M | 444.39M | 470.75M | 502.53M | 521.51M |
| Net Property, Plant & Equipment | 2.10M | 2.35M | 688.00K | 845.00K | 544.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.80M | 6.84M | 6.64M | 6.62M | 2.12M |
| Total Assets | 424.69M | 453.59M | 478.08M | 510.00M | 524.17M |
|
|
|||||
| Total Accounts Payable | 3.66M | 2.91M | 2.74M | 4.51M | 1.96M |
| Total Accrued Expenses | 16.27M | 13.24M | 15.79M | 12.88M | 12.21M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.10M | 1.07M | 591.00K | 607.00K | 308.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 21.03M | 17.23M | 19.12M | 17.99M | 14.48M |
|
|
|||||
| Total Current Liabilities | 21.03M | 17.23M | 19.12M | 17.99M | 14.48M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 880.00K | 1.16M | -- | 131.00K | 137.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 21.91M | 18.39M | 19.12M | 18.12M | 14.62M |
|
|
|||||
| Common Stock & APIC | 724.50M | 720.45M | 716.82M | 712.89M | 709.61M |
| Retained Earnings | -321.58M | -285.25M | -257.86M | -221.02M | -200.06M |
| Treasury Stock & Other | -136.00K | -- | -- | -- | -- |
| Total Common Equity | 402.78M | 435.20M | 458.96M | 491.88M | 509.56M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 402.78M | 435.20M | 458.96M | 491.88M | 509.56M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 402.78M | 435.20M | 458.96M | 491.88M | 509.56M |
|
|
|||||